Skip to content

The Dutch Cancer Foundation (KWF) granted 1.25M to OralScreen to tackle the diagnostics challenges of oral-cavity cancers.

In collaboration with KWF, NWO, and Amsterdam UMC,  Cyclomics participates in the OralScreen consortium led by Dr. J.B. Poell from the VUMC. OralScreen has the ambition of revolutionizing early cancer detection in the oral cavity.

Oral cavity cancers are often detected in a late stage, when the survival chances are severely reduced, affecting the quality of life for the patient. Like all other cancer types, DNA mutations precede the development of the disease. Together with Dr. Poell, Cyclomics aims to detect these early mutations using non-invasive strategies such as mouthwashes and swabs, potentially leading to more informed decision-making for the medical professional in the future.

more information at: